U.S. Markets closed
  • S&P Futures

    4,283.75
    -2.75 (-0.06%)
     
  • Dow Futures

    33,971.00
    -10.00 (-0.03%)
     
  • Nasdaq Futures

    13,516.25
    -7.00 (-0.05%)
     
  • Russell 2000 Futures

    1,998.20
    -3.50 (-0.17%)
     
  • Crude Oil

    90.66
    +0.16 (+0.18%)
     
  • Gold

    1,771.40
    +0.20 (+0.01%)
     
  • Silver

    19.42
    -0.04 (-0.23%)
     
  • EUR/USD

    1.0084
    -0.0008 (-0.0807%)
     
  • 10-Yr Bond

    2.8800
    -0.0130 (-0.45%)
     
  • Vix

    19.56
    -0.34 (-1.71%)
     
  • GBP/USD

    1.1917
    -0.0016 (-0.1323%)
     
  • USD/JPY

    136.1620
    +0.3000 (+0.2208%)
     
  • BTC-USD

    23,124.75
    -273.90 (-1.17%)
     
  • CMC Crypto 200

    548.56
    -9.17 (-1.64%)
     
  • FTSE 100

    7,541.85
    +26.10 (+0.35%)
     
  • Nikkei 225

    28,942.14
    -280.63 (-0.96%)
     

Creative Edge Nutrition, Inc. Announces Manufacturing Deal with Dr. Pepper Snapple Group / The American Bottling Company with its Subsidiary GIDDY UP ENERGY

BEVERLY HILLS, CA and LAKESHORE, ON / ACCESSWIRE / November 12, 2015 / GIDDY UP ENERGY PRODUCTS, INC., a subsidiary of Creative Edge Nutrition (FITX), a nutritional supplement Energy drink and Energy Bar company, focusing on active lifestyles, is pleased to announce that it has entered into a Definitive Contract Manufacturing Agreement with the Dr. Pepper/Snapple Group(R) for manufacturing of the GIDDY UP ENERGY PRODUCTS line of beverages.

Dr. Pepper Snapple Group(R) under the its manufacturing company, The American Bottling Company, Inc., will produce and bottled flavored carbonated and non-carbonated beverage products under the Giddy Up(TM) trade names and trade mark.

The American Bottling Company shall produce, package, store and ship GIDDY UP ENERGY Products(TM) Products in accordance with Good Manufacturing Practice requirements set forth in regulations promulgated under the Federal Food, Drug & Cosmetic Act (the "FFDC Act") (collectively, "GMPs"), and in compliance with the Product Specifications, quality control standards and coding systems supplied by Customer. All GIDDY UP Products(TM), Ingredients and Packaging Materials supplied by Company shall conform to Product Specifications. Company warrants that Company's Bottling Facilities currently have and at all times during the Term of this Agreement shall have a documented Hazard Analysis and Critical Control Points ("HACCP") program as required by applicable U.S. regulations.

James L. Robinson, President & CEO stated, "I have worked with Dr. Pepper/Snapple Group in the past as CEO of a former energy drink company, and I continue to have an outstanding relationship with the company. The GIDDY UP(TM) product lines have been developed to address a specific markets not currently being served and we are confident from our past relationship that Dr. Pepper/Snapple Group is the perfect manufacturing partner." We are finalizing all master distribution agreements by territory and product line which will complete our supply chains strategic relationships.

About GIDDY UP ENERGY PRODUCTS, INC

GIDDY UP ENERGY PRODUCTS, INC., based in Beverly Hills, CA is engaged in marketing and distribution of carbonated and non-carbonated energy drinks, shakes, energy bars and other nutritious, health related products. The company is a subsidiary of Creative Edge Nutrition (Symbol:FITX.PK) a Nutritional Supplement Company focused on developing innovative, high quality supplements. www.CenergyNutrition.com

CEN Biotech Inc. has the following updates:

Regarding Zoning:

Our pre-hearing with the Ontario Municipal Board is scheduled for the first week of January, 2016. CEN Biotech Inc. v. Town of Lakeshore, Ontario Municipal Board; Appeal of the Town's attempt to retroactively enforce a new bylaw on the property. The use of the property was deemed in conformance with the zoning bylaw at the time, as evidenced by the minutes of the Lakeshore Town Council meeting held November 7, 2013, wherein the economic development officer stated that CEN's property had "the correct zoning" for growing and producing medicinal marijuana. The property's facility was also approved and deemed by Health Canada to be compliant with all regulations for such a grow facility during the final inspection conducted prior to the determination of CEN's application to grow medicinal marijuana.

Regarding Judicial Review:

Cross-examinations (depositions) are scheduled for the second week of December, 2015. CEN Biotech Inc. v. The Minister of Health (s.18.1 Application for Judicial Review) Federal Court of Canada.

Regarding NAFTA Claim:

The company filed notice of intent to submit a claim to the Arbitrator under Section B of Chapter 11 of the North American Free Trade Agreement. The Government of Canada responded with an Intent to "vigorously" defend the claim. It should be noted that CEN Biotech also intends to prosecute its NAFTA claim vigorously.

Company Disclaimer

As a "penny stock" Company, within the meaning of federal and state securities law, Creative Edge Nutrition, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, Creative Edge Nutrition, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers.

Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission.

CONTACT:

CEN Biotech, Inc.
Email IR@cenergynutrition.com
Phone: 323-553-1463

SOURCE: Creative Edge Nutrition